{
    "eid": "2-s2.0-85149687513",
    "title": "Cervical cancer screening",
    "cover-date": "2021-04-22",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Cervical cancer",
        "Cervical dysplasia",
        "Cervical intraepithelial neoplasia (CIN)",
        "High-grade squamous intraepithelial lesion (HSIL)",
        "HPV",
        "HPV vaccine",
        "Human papillomavirus",
        "Low-grade squamous intraepithelial lesion (LSIL)",
        "Prevention",
        "Screening"
    ],
    "authors": [
        "Natacha Phoolcharoen",
        "Ellen S. Baker",
        "Mila Pontremoli Salcedo"
    ],
    "citedby-count": 0,
    "ref-count": 81,
    "ref-list": [
        "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries",
        "Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis",
        "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide",
        "The estimated lifetime probability of acquiring human papillomavirus in the United States",
        "Management of adolescents who have abnormal cytology and histology",
        "Human papillomavirus testing in the prevention of cervical cancer",
        "HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women",
        "Classification of papillomaviruses",
        "Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females",
        "Prevention strategies of cervical cancer in the HPV vaccine era",
        "Epidemiologic classification of human papillomavirus types associated with cervical cancer",
        "Mechanisms of human papillomavirus-induced oncogenesis",
        "The 2001 Bethesda System: Terminology for reporting results of cervical cytology",
        "2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors",
        "Natural history of established low grade cervical intraepithelial (CIN 1) lesions",
        "Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2",
        "Natural history of cervical intraepithelial neoplasia: A critical review",
        "Global cancer statistics, 2012",
        "Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women",
        "FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)",
        "HPV vaccine: Updates and highlights",
        "FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP)",
        "Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases",
        "Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions",
        "Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women",
        "Efficacy of the HPV-16/18 vaccine: Final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial",
        "A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women",
        "Human papillomavirus vaccination for adults: Updated recommendations of the advisory committee on immunization practices",
        "Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males",
        "Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: Updated systematic review and meta-analysis",
        "Advances in prevention of cervical cancer and other human papillomavirus-related diseases",
        "Pooled analysis of large and long-term safety data from the human papillomavirus-16/18-AS04-adjuvanted vaccine clinical trial programme",
        "Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States",
        "Safety profile of the 9-valent HPV vaccine: A combined analysis of 7 phase III clinical trials",
        "National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years -United States, 2017",
        "Global estimates of human papillomavirus vaccination coverage by region and income level: A pooled analysis",
        "Adolescent school-based vaccination in Australia",
        "Canadian school-based HPV vaccine programs and policy considerations",
        "Implementation of human papillomavirus immunization in the developing world",
        "Using a school-based approach to deliver immunization-global update",
        "A school-based human papillomavirus vaccination program in Barretos, Brazil: Final results of a demonstrative study",
        "Screening for cervical cancer: A systematic review and meta-analysis",
        "HPV screening for cervical cancer in rural India",
        "The diagnostic value of vaginal smears in carcinoma of the uterus. 1941",
        "Long-term trends in cancer mortality in the United States, 1930-1998",
        "Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance",
        "Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: Data from the ATHENA trial",
        "Overview of the European and North American studies on HPV testing in primary cervical cancer screening",
        "Secondary prevention of cervical cancer: ASCO resource-stratified clinical practice guideline",
        "Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: The HPV FOCAL Randomized Clinical Trial",
        "American cancer society, American society for colposcopy and cervical pathology, and American society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer",
        "Screening for cervical cancer: US preventive services task force recommendation statement",
        "How long is too long?",
        "2012 Updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors",
        "Surgery for cervical intraepithelial neoplasia",
        "Cervical cancer: A global health crisis",
        "Telementoring in gynecologic oncology training: Changing lives in Mozambique",
        "Working together to eliminate cervical cancer: A partnership across three countries \"As mudan\u00e7as no mundo s\u00e3o criadas por n\u00f3s\"",
        "Effect of VIA screening by primary health workers: Randomized controlled study in Mumbai, India",
        "Implementing community-based cervical cancer screening programs using visual inspection with acetic acid in India: A systematic review",
        "National hospital ambulatory medical care survey: 2004 emergency department summary",
        "Reasons for emergency room use among U.S. adults aged 18-64: National health interview survey, 2013 and 2014",
        "Reasons for using the emergency department: Results of the EMPATH Study",
        "Does lack of a usual source of care or health insurance increase the likelihood of an emergency department visit? Results of a national population-based study",
        "US emergency department performance on wait time and length of visit",
        "A survey of the emergency department population and their interest in preventive health education",
        "Health promotion and disease prevention in the emergency department: A feasibility study",
        "Predictors of HPV vaccine uptake among women aged 19-26: Importance of a physician's recommendation",
        "Emergency medicine physician attitudes toward HPV vaccine uptake in an emergency department setting",
        "Offering Self-Sampling Kits for HPV Testing to reach women who do not attend in the regular cervical cancer screening program",
        "Self-sampling for human papillomavirus testing among non-attenders increases attendance to the Norwegian cervical cancer screening programme",
        "Acceptability of self-sample human papillomavirus testing among medically underserved women visiting the emergency department",
        "An intervention to increase uptake of cervical cancer screening among emergency department patients: Results of a randomized pilot study"
    ],
    "affiliation": [
        {
            "affiliation-city": "Porto Alegre",
            "@id": "60101670",
            "affilname": "Universidade Federal de Ciencias da Sa\u00fade de Porto Alegre",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60101670",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Houston",
            "@id": "60015023",
            "affilname": "The University of Texas MD Anderson Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015023",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}